Generation of an isogenic human induced pluripotent stem cell line with a mutant propionyl-CoA carboxylase α subunit
This isogenic iPSC line provides an ethically unconstrained platform to investigate PA molecular mechanisms and genotype-phenotype relationships. The model enables systematic drug screening and therapeutic development while overcoming patient sample limitations.
Authors
- Zhenyao Liu
- Yanyan Tang
- Tonghe Wang (ORCID: https://orcid.org/0000-0002-8430-9755)
- Zhang Guo-fang
- Suhong Zhu
- Liwen Lin
- Jianli Wang
- Tianqi Tao
- You Wang
- Xiaohang Hu
- Yu Liu
- Yongfang Xie
Institutions
- Duke University (US)
- Chinese PLA General Hospital (CN)
- Duke Medical Center (US)
- Affiliated Hospital of Jining Medical University (CN)
- Jining Medical University (CN)
Publication Details
- Journal
- Orphanet Journal of Rare Diseases
- Published
- 2026-01-23
- DOI
- https://doi.org/10.1186/s13023-026-04197-6
- Primary Topic
- Biotin and Related Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00